Quest Diagnostics (DGX) Gross Profit (2009 - 2026)

Quest Diagnostics has reported Gross Profit for 18 years, with the latest figure at $1.0 billion in Q2 2026.

• Quarterly Gross Profit rose 8.91% year-over-year to $1.0 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $3.8 billion (up 10.16% YoY) and the FY2025 annual result came in at $3.7 billion, up 12.98% from the prior year.
• Gross Profit improved to $1.0 billion in Q2 2026 per DGX's latest filing, from $942.0 million in the prior quarter.
• Over five years, Gross Profit peaked at $1.0 billion in Q2 2026 and troughed at $736.0 million in Q4 2023.
• A 5-year average of $853.6 million and a median of $850.0 million in 2022 frame the typical range for Gross Profit.
• The sharpest annual moves came in 2022 and 2025: Gross Profit slipped 26.12% in 2022, then grew 17.29% in 2025.
• Over 5 years, Gross Profit stood at $758.0 million in 2022, then dropped by 2.9% to $736.0 million in 2023, then rose by 16.58% to $858.0 million in 2024, then climbed by 6.06% to $910.0 million in 2025, then increased by 12.86% to $1.0 billion in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $1.0 billion, $942.0 million, and $910.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.